| Cat. No. |
Product Name |
Information |
| PC-24200 |
Zoldonrasib
KRAS inhibitor
|
Zoldonrasib (RMC-9805) is a potent, selective covalent peptide-linked macrocyclic dipeptidic inhibitor of KRAS G12D. |
| PC-24126 |
D3S-001
KRAS G12C inhibitor
|
Elisrasib (D3S-001) is a potent, selective, CNS-penetrable, covalent inhibitor of GDP-bound KRAS G12C inhibitor, decreases cellular active KRAS proteins in a dose-dependent manner (IC50=0.6 nM) in NCI-H358 cells. |
| PC-23832 |
RMC-9805
KRAS G12D inhibitor
|
RMC-9805 is a potent, selective and covalent inhibitor of KRAS G12D with EC50 of 23 nM (AsPC-1, pERK), highly selective for crosslinking RAS G12D(ON). |
| PC-22656 |
HRS-4642
KRAS G12D inhibitor
|
HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor with SPR KD of 0.083 nM, >20-fold selective over wild-type KRAS and KRAS G12C. |
| PC-22626 |
Glecirasib
KRAS G12C inhibitor
|
Glecirasib (JAB-21822) is a highly selective, covalent oral KRAS G12C inhibitor with IC50 of 1.6 nM (SOS1-mediated guanine nucleotide exchange, GDP- KRAS G12C) and IC50 of 7.3 nM in Phospho-ERK inhibition assay in NCI-H358 cells. |
| PC-22125 |
RMC-6236
Ras inhibitor
|
Daraxonrasib (RMC-6236) is a first-in-class broad-spectrum RAS (ON) multi-selective inhibits, inhibits active state of both mutant and wild-type KRAS, NRAS and HRAS variants. |
| PC-22123 |
BBO-8520
KRAS G12C inhibitor
|
BBO-8520 is a potent, selective and covalent inhibitor of KRAS G12C (ON), locks GTP-bound KRASG12C in the state 1 conformation resulting in rapid and complete blockade of effector binding. |
| PC-21775 |
ADT-007
Ras inhibitor
|
ADT-007 (ADT007) is a potent, specific pan-RAS inhibitor, shows potential to circumvent resistance to mutant-specific KRAS inhibitors and activates antitumor immunity. |
| PC-21542 |
CSC01
KRAS G13D inhibitor
|
CSC01 (CSC057253844) is a small molecule inhibitor of oncogenic KRAS mutant G13D (KRAS-G13D). |
| PC-21263 |
ERAS-5024
KRAS G12D inhibitor
|
ERAS-5024 (ERAS5024) is a potent and selective KRAS G12D inhibitor with IC50 of 0.86 nM in RAS-RAF binding assays, inhibits ERK1/2 phosphorylation (pERK) formation with IC50 of 2.1 nM in AsPC-1 cell-based assays. |
| PC-21063 |
RMC-4998
KRAS G12C inhibitor
|
RMC-4998 (RM-029) is a tricomplex inhibitor that targets the active state or GTP-bound state of KRAS G12C, selectively inhibits the proliferation of KRASG12C mutant cells with mean IC50 of 0.28 nM. |
| PC-20878 |
BI-2493
pan-KRAS inhibitor
|
BI-2493 is a structural analogue of BI-2865 for in vivo administration, BI-2493 a potent, inactive state selective, non-covalent pan KRAS inhibitor. |
